Capha Pharmaceuticals Inc. Share Price

Stocks

31/07/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
28/05/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
24/04/25	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
23/04/25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
17/10/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
29/07/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
30/05/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/04/24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
25/04/24	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
28/11/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
28/08/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
30/05/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
26/04/23	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	12/01/2004

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	12/01/2004
Herbert Leary BRD	Director/Board Member	-	24/10/2010
James Brown CHM	Chairman	-	30/10/2002

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
11/11/21	Janice Brown	Free	Director	888,036	1.3783%
11/11/21	James Brown	Free	Chief Executive Officer	888,036	1.3783%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-99.00%	-	-	64
ELI LILLY AND COMPANY	+2.68%	+3.87%	+58.22%	+114.68%	1,026B
JOHNSON & JOHNSON	+0.56%	+1.27%	+53.29%	+68.65%	649B
ABBVIE INC.	+0.02%	+0.99%	+19.10%	+73.58%	468B
ROCHE HOLDING AG	+0.06%	+0.25%	+37.03%	+45.71%	352B
NOVARTIS AG	+1.16%	+4.10%	+21.99%	+29.39%	271B
ASTRAZENECA PLC	-0.24%	+2.18%	+10.14%	+12.26%	256B
AMGEN INC.	-0.01%	+7.89%	+41.57%	+51.68%	220B
GILEAD SCIENCES, INC.	-1.11%	+1.36%	+30.85%	+99.56%	188B
NOVO NORDISK A/S	+0.30%	-7.19%	-32.43%	-60.56%	170B
Average	+0.44%	+1.26%	+26.64%	+48.33%	399.9B
Weighted average by Cap.	+1.08%	+1.26%	+37.30%	+67.68%